Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Givinostat	118
Overall Study	STARTED	Placebo	61
Overall Study	All Enrolled Subjects	Givinostat	118
Overall Study	All Enrolled Subjects	Placebo	61
Overall Study	ITT Population	Givinostat	118
Overall Study	ITT Population	Placebo	61
Overall Study	Safety Set	Givinostat	118
Overall Study	Safety Set	Placebo	61
Overall Study	PK Analysis Set	Givinostat	117
Overall Study	PK Analysis Set	Placebo	0
Overall Study	Target Population	Givinostat	81
Overall Study	Target Population	Placebo	39
Overall Study	MR Cohort	Givinostat	77
Overall Study	MR Cohort	Placebo	37
Overall Study	COMPLETED	Givinostat	111
Overall Study	COMPLETED	Placebo	59
Overall Study	NOT COMPLETED	Givinostat	7
Overall Study	NOT COMPLETED	Placebo	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02851797/flow